4//SEC Filing
Dimension Therapeutics, Inc. 4
Accession 0001209191-16-122631
CIK 0001592288operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:36 PM ET
Size
5.4 KB
Accession
0001209191-16-122631
Insider Transaction Report
Form 4
Dybbs Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-05-19+32,069→ 32,069 totalExercise: $7.08Exp: 2026-05-18→ Common Stock (32,069 underlying)
Footnotes (1)
- [F1]The options shall vest in full on the earlier of May 19, 2017 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board.
Documents
Issuer
Dimension Therapeutics, Inc.
CIK 0001592288
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001592288
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:36 PM ET
- Size
- 5.4 KB